AMIKACIN SULFATE

AMIKACIN SULFATE was reported 1741 times

AMIKACIN SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALPHA 1 FOETOPROTEIN AMNIOTIC FLUID DECREASED 1 1.0000
1 ANTIMICROBIAL SUSCEPTIBILITY TEST INTERMEDIATE 4 0.3636
2 CARBOHYDRATE ANTIGEN 242 INCREASED 1 0.2500
3 BENIGN SOFT TISSUE NEOPLASM 5 0.1316
4 HIV WASTING SYNDROME 3 0.0833
5 GALLSTONE ILEUS 3 0.0682
6 ANTITHROMBIN III 1 0.0625
7 MYCOBACTERIAL PERITONITIS 5 0.0526
8 BARREL CHEST 1 0.0526
9 NEONATAL CANDIDA INFECTION 2 0.0465
10 LYMPHANGIECTASIA INTESTINAL 2 0.0400
11 MYCOBACTERIUM FORTUITUM INFECTION 7 0.0378
12 POSTHAEMORRHAGIC HYDROCEPHALUS 2 0.0345
13 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 9 0.0332
14 CENTRAL VENOUS PRESSURE DECREASED 1 0.0286
15 LYMPHANGIECTASIA 2 0.0286
16 ANTIBIOTIC ASSOCIATED COLITIS 1 0.0270
17 BARTTER'S SYNDROME 1 0.0263
18 ASPERGILLUS TEST POSITIVE 8 0.0260
19 BOTRYOMYCOSIS 1 0.0256
20 OSTEOMYELITIS BACTERIAL 7 0.0255
21 CATHETER SITE HYPERSENSITIVITY 1 0.0250
22 ACETONAEMIA 6 0.0238
23 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0226
24 INTRACARDIAC MASS 4 0.0226
25 CAROTID PULSE DECREASED 1 0.0222
26 BLOOD PRESSURE MEASUREMENT 14 0.0218
27 ATYPICAL MYCOBACTERIUM TEST POSITIVE 2 0.0206
28 HEPATOSPLENIC CANDIDIASIS 3 0.0204
29 BURKITT'S LYMPHOMA 2 0.0190
30 DOSING ERROR 3 0.0179
31 BLOOD ERYTHROPOIETIN DECREASED 1 0.0172
32 ANAL CANDIDIASIS 1 0.0172
33 THALAMIC INFARCTION 10 0.0169
34 MYCOBACTERIUM ABSCESSUS INFECTION 12 0.0168
35 ADRENAL ATROPHY 1 0.0161
36 DEAFNESS PERMANENT 3 0.0153
37 ANAL HYPOAESTHESIA 1 0.0147
38 ALKALOSIS HYPOCHLORAEMIC 2 0.0143
39 OTOTOXICITY 25 0.0135
40 HEPATIC VEIN OCCLUSION 2 0.0127
41 CARNITINE DECREASED 1 0.0122
42 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 2 0.0110
43 WRONG PRODUCT STORED 3 0.0106
44 MYCOBACTERIUM AVIUM COMPLEX INFECTION 27 0.0100
45 CARDIAC NEOPLASM UNSPECIFIED 2 0.0100
46 PNEUMOCYSTIS CARINII PNEUMONIA 2 0.0099
47 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
48 RED BLOOD CELL TRANSFUSION 4 0.0098
49 ANXIETY DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0095
50 CLOSTRIDIUM BACTERAEMIA 2 0.0093
51 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 3 0.0090
52 CHRONIC RESPIRATORY DISEASE 3 0.0085
53 ANTERIOR CHAMBER FIBRIN 1 0.0078
54 ASPIRATION BONE MARROW ABNORMAL 1 0.0074
55 NECROTISING ENTEROCOLITIS NEONATAL 3 0.0074
56 KLEBSIELLA BACTERAEMIA 7 0.0074
57 ANTITHROMBIN III DECREASED 2 0.0073
58 CARDIAC ARREST NEONATAL 1 0.0072
59 NECROTISING MYOSITIS 6 0.0069
60 AUTOIMMUNE NEUTROPENIA 2 0.0069
61 CANDIDA SEPSIS 6 0.0067
62 ATYPICAL MYCOBACTERIAL INFECTION 9 0.0064
63 ECHOLALIA 2 0.0063
64 LARYNGEAL DISCOMFORT 4 0.0063
65 ACID FAST BACILLI INFECTION 1 0.0062
66 ANAL SKIN TAGS 1 0.0061
67 PROCALCITONIN INCREASED 7 0.0060
68 CARNITINE DEFICIENCY 1 0.0058
69 ANGULAR CHEILITIS 4 0.0058
70 ANTI-PLATELET ANTIBODY POSITIVE 1 0.0058
71 AEROPHAGIA 1 0.0057
72 TRACHEAL HAEMORRHAGE 2 0.0057
73 WEIGHT BEARING DIFFICULTY 15 0.0056
74 COMA SCALE ABNORMAL 16 0.0055
75 FIBROMA 5 0.0054
76 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0054
77 GENERALISED BULLOUS FIXED DRUG ERUPTION 2 0.0054
78 SERRATIA INFECTION 4 0.0054
79 PSEUDOMEMBRANOUS COLITIS 12 0.0054
80 PERFORMANCE STATUS DECREASED 25 0.0054
81 ROTAVIRUS INFECTION 3 0.0052
82 ANAEMIA FOLATE DEFICIENCY 1 0.0052
83 ACINETOBACTER TEST POSITIVE 1 0.0052
84 BONE MARROW DEPRESSION 5 0.0051
85 BRONCHOPULMONARY DYSPLASIA 4 0.0050
86 NEUTROPENIC COLITIS 10 0.0048
87 HAEMOBILIA 2 0.0048
88 FUNGAL SEPSIS 4 0.0048
89 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 1 0.0048
90 PSEUDOMONAL BACTERAEMIA 4 0.0047
91 BLOOD STEM CELL TRANSPLANT FAILURE 1 0.0047
92 PATHOGEN RESISTANCE 42 0.0046
93 PULMONARY CAVITATION 4 0.0046
94 LUNG TRANSPLANT REJECTION 3 0.0045
95 POSTRENAL FAILURE 2 0.0045
96 ILEAL PERFORATION 3 0.0045
97 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 2 0.0044
98 NEONATAL DISORDER 7 0.0044
99 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
100 KLEBSIELLA INFECTION 22 0.0043
101 BONE MARROW NECROSIS 1 0.0043
102 HYPOCHLORAEMIA 5 0.0043
103 PELVIC FLUID COLLECTION 3 0.0043
104 CARDIAC VALVE VEGETATION 2 0.0041
105 TUMOUR INVASION 2 0.0041
106 MYCOBACTERIUM CHELONAE INFECTION 3 0.0041
107 PYURIA 4 0.0040
108 HYPOFIBRINOGENAEMIA 4 0.0040
109 PROTEIN-LOSING GASTROENTEROPATHY 2 0.0040
110 RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0040
111 SYSTEMIC CANDIDA 10 0.0040
112 CAPILLARY LEAK SYNDROME 8 0.0039
113 MYOPERICARDITIS 3 0.0038
114 BASOPHIL COUNT DECREASED 1 0.0038
115 BLOOD CORTISOL INCREASED 1 0.0038
116 SEPSIS NEONATAL 3 0.0037
117 HYPOPROTEINAEMIA 7 0.0037
118 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 3 0.0036
119 DEAFNESS NEUROSENSORY 12 0.0036
120 RETINOPATHY OF PREMATURITY 2 0.0036
121 OEDEMATOUS PANCREATITIS 2 0.0036
122 ENCEPHALOMALACIA 2 0.0036
123 KLEBSIELLA SEPSIS 4 0.0035
124 ACUTE LYMPHOCYTIC LEUKAEMIA 10 0.0035
125 PSEUDOMONAL SEPSIS 6 0.0034
126 ENGRAFTMENT SYNDROME 2 0.0034
127 DERMO-HYPODERMITIS 2 0.0034
128 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 2 0.0033
129 PNEUMONIA PSEUDOMONAL 5 0.0033
130 CARBON DIOXIDE ABNORMAL 1 0.0032
131 PSEUDOMONAS INFECTION 27 0.0031
132 NEUTROPENIC INFECTION 3 0.0031
133 PLATELET TRANSFUSION 4 0.0031
134 DUST ALLERGY 3 0.0031
135 DUODENAL PERFORATION 3 0.0031
136 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
137 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 15 0.0030
138 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
139 CATHETER RELATED INFECTION 3 0.0030
140 STENOTROPHOMONAS INFECTION 4 0.0029
141 LONG QT SYNDROME 7 0.0029
142 BLAST CELL COUNT INCREASED 3 0.0029
143 SCEDOSPORIUM INFECTION 2 0.0028
144 INTRAVENTRICULAR HAEMORRHAGE 7 0.0028
145 MENINGITIS BACTERIAL 4 0.0028
146 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
147 ABSCESS BACTERIAL 1 0.0028
148 HYDROCEPHALUS 15 0.0028
149 HYPERTRANSAMINASAEMIA 19 0.0027
150 COMA HEPATIC 2 0.0027
151 BOVINE TUBERCULOSIS 1 0.0026
152 HYPERLACTACIDAEMIA 7 0.0026
153 CALCULUS URINARY 4 0.0026
154 HYPERVENTILATION 15 0.0026
155 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
156 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
157 FUNGAEMIA 4 0.0025
158 PNEUMONIA STAPHYLOCOCCAL 5 0.0025
159 ENTEROCOCCAL SEPSIS 2 0.0025
160 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 1 0.0025
161 BONE ABSCESS 1 0.0025
162 ACOUSTIC NEUROMA 1 0.0024
163 DYSBIOSIS 2 0.0024
164 BLOOD ELECTROLYTES ABNORMAL 3 0.0024
165 DYSCHROMATOPSIA 2 0.0024
166 DRUG RESISTANCE 62 0.0024
167 LEUKAEMIA RECURRENT 4 0.0024
168 DEAFNESS BILATERAL 4 0.0024
169 FEBRILE BONE MARROW APLASIA 10 0.0024
170 DISSEMINATED INTRAVASCULAR COAGULATION 33 0.0023
171 ACUTE MYELOID LEUKAEMIA RECURRENT 5 0.0023
172 IMMUNE RECONSTITUTION SYNDROME 3 0.0023
173 ENTEROCOCCAL INFECTION 11 0.0023
174 ABDOMINAL SEPSIS 2 0.0023
175 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
176 VENOOCCLUSIVE LIVER DISEASE 11 0.0022
177 CAECITIS 1 0.0022
178 INTESTINAL INFARCTION 2 0.0022
179 HYPOALBUMINAEMIA 17 0.0022
180 ANEURYSM RUPTURED 2 0.0022
181 METASTASES TO ADRENALS 2 0.0022
182 PRODUCT APPEARANCE CONFUSION 2 0.0022
183 BUNDLE BRANCH BLOCK 2 0.0021
184 POTENTIATING DRUG INTERACTION 7 0.0021
185 ANAEMIA NEONATAL 1 0.0021
186 BRONCHOPULMONARY ASPERGILLOSIS 16 0.0021
187 CEREBRAL ARTERY STENOSIS 1 0.0020
188 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
189 BODY HEIGHT INCREASED 1 0.0020
190 PNEUMONIA FUNGAL 8 0.0020
191 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
192 ILEAL ULCER 2 0.0020
193 AORTIC VALVE CALCIFICATION 1 0.0019
194 HYPERSENSITIVITY VASCULITIS 5 0.0019
195 RADICULOPATHY 5 0.0019
196 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1 0.0019
197 OPTIC NERVE DISORDER 3 0.0019
198 NEPHROPATHY TOXIC 21 0.0019
199 BLOOD GASES ABNORMAL 1 0.0019
200 BRONCHOSTENOSIS 1 0.0018
201 STAPHYLOCOCCAL SEPSIS 9 0.0018
202 MYOCARDIAL INJURY 2 0.0018
203 APNOEIC ATTACK 1 0.0018
204 OROPHARYNGEAL DISCOMFORT 16 0.0018
205 PNEUMATOSIS INTESTINALIS 5 0.0018
206 BLOOD UREA INCREASED 29 0.0017
207 FANCONI SYNDROME ACQUIRED 3 0.0017
208 BLOOD ALKALINE PHOSPHATASE INCREASED 42 0.0017
209 TOXIC SKIN ERUPTION 17 0.0017
210 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
211 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
212 ASPERGILLUS INFECTION 11 0.0017
213 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
214 BLOOD CULTURE POSITIVE 5 0.0017
215 GRAFT VERSUS HOST DISEASE 12 0.0017
216 UPPER RESPIRATORY TRACT INFLAMMATION 2 0.0017
217 HYPERCAPNIA 5 0.0017
218 PARADOXICAL DRUG REACTION 6 0.0016
219 VENTRICULAR FIBRILLATION 18 0.0016
220 MULTIPLE-DRUG RESISTANCE 5 0.0016
221 BILIARY TRACT INFECTION 1 0.0016
222 RENAL ATROPHY 2 0.0016
223 SMALL INTESTINAL PERFORATION 3 0.0016
224 CATHETER SITE HAEMORRHAGE 4 0.0016
225 EOSINOPHILIA 28 0.0016
226 BONE MARROW TRANSPLANT 3 0.0016
227 NECROTISING COLITIS 2 0.0016
228 VASCULAR DEVICE INFECTION 7 0.0015
229 LIVER ABSCESS 5 0.0015
230 RETINAL DEGENERATION 2 0.0015
231 MUCORMYCOSIS 4 0.0015
232 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
233 ASPERGILLOSIS 2 0.0015
234 PNEUMONIA BACTERIAL 14 0.0015
235 LUNG OPACITY 4 0.0015
236 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
237 CANDIDIASIS 6 0.0015
238 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
239 EFFUSION 2 0.0015
240 HYPERURICAEMIA 6 0.0015
241 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
242 ANASTOMOTIC LEAK 1 0.0014
243 NEUTROPENIC SEPSIS 10 0.0014
244 DERMATITIS EXFOLIATIVE 7 0.0014
245 CARDIAC SEPTAL DEFECT 1 0.0014
246 ANTIBODY TEST ABNORMAL 1 0.0014
247 CALCULUS URETERIC 1 0.0014
248 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
249 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
250 CUTANEOUS VASCULITIS 5 0.0014
251 BRAIN CONTUSION 1 0.0014
252 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
253 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
254 CEREBRAL VASOCONSTRICTION 1 0.0014
255 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
256 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
257 SUPERINFECTION 2 0.0013
258 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
259 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0013
260 CYTOMEGALOVIRUS COLITIS 3 0.0013
261 CANDIDA INFECTION 22 0.0013
262 VASCULITIS 15 0.0013
263 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
264 BRONCHIAL DISORDER 2 0.0013
265 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 33 0.0013
266 ESCHERICHIA BACTERAEMIA 3 0.0013
267 SEPTIC SHOCK 55 0.0013
268 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
269 CYSTITIS HAEMORRHAGIC 5 0.0012
270 LEUKOCYTOCLASTIC VASCULITIS 2 0.0012
271 BACTERIAL SEPSIS 4 0.0012
272 ANAL ULCER 1 0.0012
273 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
274 BALANOPOSTHITIS 1 0.0012
275 ILLUSION 2 0.0012
276 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
277 INTERCEPTED PRODUCT DISPENSING ERROR 2 0.0012
278 CARDIAC FAILURE ACUTE 8 0.0012
279 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
280 AMAUROSIS 1 0.0012
281 ENTERITIS INFECTIOUS 2 0.0012
282 FIXED ERUPTION 2 0.0012
283 MYCOBACTERIAL INFECTION 2 0.0012
284 BLOOD CREATININE ABNORMAL 4 0.0012
285 AXONAL NEUROPATHY 1 0.0011
286 CARDIAC OUTPUT DECREASED 1 0.0011
287 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
288 BLOOD CREATINE INCREASED 5 0.0011
289 CHOLANGITIS 7 0.0011
290 ABDOMINAL NEOPLASM 1 0.0011
291 LIVER TRANSPLANT REJECTION 2 0.0011
292 ARTERIOVENOUS MALFORMATION 1 0.0011
293 C-REACTIVE PROTEIN INCREASED 40 0.0011
294 HEPATIC FUNCTION ABNORMAL 41 0.0011
295 RASH PUSTULAR 8 0.0011
296 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
297 RASH MORBILLIFORM 3 0.0011
298 STATUS EPILEPTICUS 12 0.0011
299 CATHETER SITE INFECTION 4 0.0011
300 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
301 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
302 ESCHERICHIA SEPSIS 3 0.0010
303 TRAUMATIC LUNG INJURY 2 0.0010
304 DEAFNESS 27 0.0010
305 BRAIN OEDEMA 13 0.0010
306 APLASIA 2 0.0010
307 PYELONEPHRITIS ACUTE 2 0.0010
308 HEPATITIS FULMINANT 3 0.0010
309 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
310 INFLAMMATORY MARKER INCREASED 5 0.0010
311 HYPERNATRAEMIA 5 0.0010
312 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
313 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
314 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
315 PETIT MAL EPILEPSY 5 0.0010
316 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
317 MICROCYTIC ANAEMIA 2 0.0010
318 APLASTIC ANAEMIA 5 0.0010
319 LUNG ABSCESS 2 0.0010
320 ABDOMINAL ADHESIONS 3 0.0009
321 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
322 RASH MACULO-PAPULAR 21 0.0009
323 ASTERIXIS 1 0.0009
324 FEBRILE NEUTROPENIA 62 0.0009
325 CD4 LYMPHOCYTES DECREASED 2 0.0009
326 EXOPHTHALMOS 2 0.0009
327 ANURIA 8 0.0009
328 BONE NEOPLASM 1 0.0009
329 ANAL ABSCESS 5 0.0009
330 PYELONEPHRITIS 8 0.0009
331 LYMPHOCYTE COUNT INCREASED 3 0.0009
332 HEPATOMEGALY 9 0.0009
333 INTESTINAL ISCHAEMIA 5 0.0009
334 NOSOCOMIAL INFECTION 2 0.0009
335 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 2 0.0009
336 HEPATOTOXICITY 20 0.0009
337 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
338 GASTROINTESTINAL INFLAMMATION 7 0.0009
339 HYPOTHERMIA 9 0.0009
340 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
341 CATHETER RELATED COMPLICATION 1 0.0009
342 BONE MARROW FAILURE 18 0.0009
343 DISTRIBUTIVE SHOCK 2 0.0009
344 BLOOD FIBRINOGEN DECREASED 1 0.0009
345 BRONCHOPNEUMONIA 3 0.0009
346 CARDIOVASCULAR DISORDER 22 0.0009
347 BLOOD URIC ACID INCREASED 5 0.0009
348 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
349 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
350 BILIRUBIN CONJUGATED INCREASED 2 0.0009
351 ESCHERICHIA INFECTION 7 0.0009
352 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
353 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0008
354 HAEMORRHAGIC DIATHESIS 3 0.0008
355 LACUNAR INFARCTION 2 0.0008
356 RADIUS FRACTURE 2 0.0008
357 ATELECTASIS 8 0.0008
358 HAEMATOLOGICAL INFECTION 2 0.0008
359 HYPOPHOSPHATAEMIA 6 0.0008
360 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
361 OLIGURIA 5 0.0008
362 ALLERGY TO CHEMICALS 1 0.0008
363 AMPUTATION 1 0.0008
364 VENOOCCLUSIVE DISEASE 2 0.0008
365 BRAIN ABSCESS 2 0.0008
366 HAEMODYNAMIC INSTABILITY 6 0.0008
367 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
368 NEUTROPHIL COUNT DECREASED 32 0.0008
369 HYPOKALAEMIA 36 0.0008
370 HEPATOSPLENOMEGALY 2 0.0008
371 LYMPHOPENIA 11 0.0008
372 LEUKOCYTOSIS 14 0.0008
373 HYPERBILIRUBINAEMIA 8 0.0008
374 ACUTE MYELOID LEUKAEMIA 12 0.0008
375 HEPATITIS TOXIC 2 0.0008
376 ORAL INFECTION 3 0.0008
377 PULMONARY HAEMORRHAGE 6 0.0008
378 DRUG-INDUCED LIVER INJURY 24 0.0008
379 SEPSIS 85 0.0008
380 ORAL CANDIDIASIS 10 0.0008
381 BLOOD ALBUMIN DECREASED 6 0.0008
382 MULTI-ORGAN FAILURE 13 0.0008
383 IMPAIRED WORK ABILITY 16 0.0007
384 ASPARTATE AMINOTRANSFERASE INCREASED 39 0.0007
385 GASTRIC PERFORATION 2 0.0007
386 CARBON DIOXIDE INCREASED 1 0.0007
387 ASPIRATION 8 0.0007
388 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
389 DEAFNESS UNILATERAL 4 0.0007
390 PLEURITIC PAIN 2 0.0007
391 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
392 GASTROINTESTINAL PERFORATION 3 0.0007
393 THROMBOTIC MICROANGIOPATHY 7 0.0007
394 CHRONIC FATIGUE SYNDROME 1 0.0007
395 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
396 HAEMODIALYSIS 6 0.0007
397 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
398 PANCREATITIS ACUTE 16 0.0007
399 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
400 ALVEOLITIS 1 0.0007
401 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
402 AUDITORY DISORDER 1 0.0007
403 RESPIRATORY SYMPTOM 2 0.0007
404 CHORIORETINOPATHY 1 0.0007
405 PULMONARY TUBERCULOSIS 3 0.0007
406 GRANULOCYTOPENIA 4 0.0007
407 AGRANULOCYTOSIS 13 0.0007
408 PERITONITIS BACTERIAL 7 0.0007
409 ENTEROCOLITIS 4 0.0007
410 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
411 TUMOUR LYSIS SYNDROME 6 0.0007
412 BILIARY DILATATION 1 0.0007
413 ILEUS PARALYTIC 3 0.0007
414 HYDRONEPHROSIS 5 0.0007
415 SUSPECTED OFF LABEL USE 3 0.0007
416 DYSAESTHESIA 2 0.0007
417 SHOCK 15 0.0007
418 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
419 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
420 BACTERIAL INFECTION 12 0.0006
421 TORSADE DE POINTES 5 0.0006
422 RESPIRATORY RATE DECREASED 2 0.0006
423 BLOOD BILIRUBIN INCREASED 17 0.0006
424 MALNUTRITION 7 0.0006
425 METABOLIC ACIDOSIS 20 0.0006
426 ACUTE LEUKAEMIA 1 0.0006
427 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
428 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
429 LIVER INJURY 15 0.0006
430 BRADYARRHYTHMIA 1 0.0006
431 ANTIBODY TEST POSITIVE 1 0.0006
432 ELECTROLYTE IMBALANCE 7 0.0006
433 CYTOMEGALOVIRUS INFECTION 10 0.0006
434 COAGULOPATHY 10 0.0006
435 BRONCHIECTASIS 4 0.0006
436 FACE OEDEMA 10 0.0006
437 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
438 BACTERAEMIA 7 0.0006
439 BLADDER NEOPLASM 1 0.0006
440 ENDOCARDITIS 3 0.0006
441 DEVICE RELATED INFECTION 9 0.0006
442 CACHEXIA 3 0.0006
443 PERITONITIS 12 0.0006
444 GRANULOMA 2 0.0006
445 URINE OUTPUT DECREASED 5 0.0006
446 SERUM FERRITIN INCREASED 3 0.0006
447 NECROTISING FASCIITIS 2 0.0006
448 BLOOD CREATININE INCREASED 37 0.0006
449 PULMONARY TOXICITY 4 0.0006
450 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
451 PURPURA 5 0.0006
452 LUNG TRANSPLANT 2 0.0006
453 DRUG ERUPTION 10 0.0006
454 LIVER DISORDER 25 0.0006
455 PLATELET COUNT DECREASED 60 0.0006
456 RESPIRATORY FAILURE 41 0.0006
457 CARDIOGENIC SHOCK 8 0.0006
458 THROMBOCYTOPENIA 62 0.0006
459 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
460 DERMATITIS BULLOUS 4 0.0006
461 MONOCYTE COUNT INCREASED 2 0.0006
462 STAPHYLOCOCCAL INFECTION 18 0.0005
463 BODY TEMPERATURE ABNORMAL 1 0.0005
464 VIRAL MUTATION IDENTIFIED 2 0.0005
465 WOUND HAEMORRHAGE 2 0.0005
466 TRANSAMINASES INCREASED 12 0.0005
467 STREPTOCOCCAL INFECTION 3 0.0005
468 PULMONARY MASS 8 0.0005
469 INTESTINAL PERFORATION 6 0.0005
470 PROTEIN TOTAL DECREASED 2 0.0005
471 BILE DUCT OBSTRUCTION 1 0.0005
472 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
473 HYPERTHERMIA 4 0.0005
474 TINNITUS 24 0.0005
475 CHOLESTASIS 10 0.0005
476 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
477 PANCYTOPENIA 29 0.0005
478 RENAL FAILURE ACUTE 22 0.0005
479 VIRAL LOAD INCREASED 2 0.0005
480 APNOEA 4 0.0005
481 SKIN LESION 14 0.0005
482 BICYTOPENIA 1 0.0005
483 RENAL TUBULAR NECROSIS 5 0.0005
484 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
485 PNEUMOTHORAX 8 0.0005
486 HYPERLIPIDAEMIA 6 0.0005
487 ANORECTAL DISORDER 1 0.0005
488 HEARING IMPAIRED 3 0.0005
489 PYREXIA 172 0.0005
490 PLEURAL EFFUSION 30 0.0005
491 ARTHRITIS BACTERIAL 2 0.0005
492 CHEST INJURY 1 0.0005
493 ILEUS 6 0.0005
494 VENTRICULAR EXTRASYSTOLES 5 0.0005
495 RENAL IMPAIRMENT 40 0.0005
496 HYPOCALCAEMIA 9 0.0005
497 CIRCULATORY COLLAPSE 8 0.0005
498 SKIN HYPERPIGMENTATION 4 0.0005
499 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
500 OCULAR ICTERUS 2 0.0005
501 RESPIRATORY TRACT INFECTION 12 0.0005
502 TONGUE DISCOLOURATION 2 0.0005
503 CEREBELLAR SYNDROME 1 0.0005
504 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
505 IMMUNOSUPPRESSION 4 0.0005
506 CATHETERISATION CARDIAC 2 0.0005
507 PAPILLOEDEMA 2 0.0004
508 LEUKOPENIA 22 0.0004
509 ACUTE KIDNEY INJURY 67 0.0004
510 ISCHAEMIA 2 0.0004
511 LOCALISED OEDEMA 2 0.0004
512 HAEMOPTYSIS 12 0.0004
513 GASTRITIS EROSIVE 2 0.0004
514 ERYTHEMA MULTIFORME 4 0.0004
515 HEPATIC ENCEPHALOPATHY 4 0.0004
516 VAGINAL INFECTION 2 0.0004
517 HEPATOCELLULAR INJURY 6 0.0004
518 SPUTUM DISCOLOURED 4 0.0004
519 CARDIAC TAMPONADE 2 0.0004
520 GASTROINTESTINAL TOXICITY 2 0.0004
521 RASH VESICULAR 2 0.0004
522 LUNG DISORDER 20 0.0004
523 BREATH SOUNDS ABNORMAL 2 0.0004
524 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
525 GENERALISED OEDEMA 5 0.0004
526 ORGANISING PNEUMONIA 2 0.0004
527 PROTEIN URINE PRESENT 2 0.0004
528 RESPIRATORY DISTRESS 11 0.0004
529 HEPATIC FAILURE 12 0.0004
530 DYSLIPIDAEMIA 2 0.0004
531 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
532 ACIDOSIS 3 0.0004
533 PROCEDURAL COMPLICATION 3 0.0004
534 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
535 PERICARDIAL EFFUSION 9 0.0004
536 AORTIC ARTERIOSCLEROSIS 1 0.0004
537 HAEMOLYSIS 3 0.0004
538 ANOREXIA 5 0.0004
539 BLOOD CHLORIDE DECREASED 1 0.0004
540 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
541 WHITE BLOOD CELL COUNT DECREASED 42 0.0004
542 FOETAL DEATH 2 0.0004
543 SKIN NECROSIS 2 0.0004
544 TONSILLITIS 2 0.0004
545 MALABSORPTION 2 0.0004
546 NEUTROPENIA 52 0.0004
547 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
548 CARDIAC ARREST 31 0.0004
549 ANIMAL BITE 1 0.0004
550 VIROLOGIC FAILURE 2 0.0004
551 DRUG INTERACTION 59 0.0004
552 SHOCK HAEMORRHAGIC 3 0.0004
553 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
554 POLYURIA 3 0.0004
555 BLOOD PHOSPHORUS INCREASED 1 0.0004
556 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
557 CYSTIC FIBROSIS 2 0.0004
558 VIRAL INFECTION 12 0.0004
559 HAEMOGLOBIN DECREASED 37 0.0004
560 EOSINOPHIL COUNT INCREASED 3 0.0004
561 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
562 NECROSIS 2 0.0004
563 HYPERGLYCAEMIA 13 0.0004
564 DERMATITIS CONTACT 4 0.0004
565 HYPERTONIA 2 0.0003
566 MYOCARDITIS 4 0.0003
567 SKIN ATROPHY 2 0.0003
568 MYELODYSPLASTIC SYNDROME 5 0.0003
569 PRODUCT LABEL CONFUSION 2 0.0003
570 HYPERKALAEMIA 12 0.0003
571 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
572 SPLENOMEGALY 4 0.0003
573 LUNG INFILTRATION 3 0.0003
574 LYMPHOCYTE COUNT DECREASED 6 0.0003
575 COVID-19 PNEUMONIA 4 0.0003
576 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
577 PLEURISY 2 0.0003
578 PROTHROMBIN TIME PROLONGED 2 0.0003
579 SYMPTOM RECURRENCE 2 0.0003
580 MYELOSUPPRESSION 12 0.0003
581 CEREBROVASCULAR DISORDER 1 0.0003
582 BONE MARROW DISORDER 1 0.0003
583 FUNGAL INFECTION 11 0.0003
584 STOMATITIS 20 0.0003
585 DERMATITIS ACNEIFORM 2 0.0003
586 CYTOPENIA 4 0.0003
587 SPEECH DISORDER 17 0.0003
588 LYMPHOMA 5 0.0003
589 HEPATIC STEATOSIS 6 0.0003
590 LUNG INFECTION 5 0.0003
591 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
592 BLOOD CREATININE DECREASED 1 0.0003
593 DERMATITIS ALLERGIC 4 0.0003
594 BILE DUCT STONE 1 0.0003
595 ACUTE RESPIRATORY FAILURE 6 0.0003
596 ANAEMIA 59 0.0003
597 HEPATITIS ACUTE 2 0.0003
598 HERPES SIMPLEX 2 0.0003
599 PLATELET COUNT INCREASED 4 0.0003
600 TENDON DISORDER 2 0.0003
601 MUCOSAL INFLAMMATION 8 0.0003
602 PRODUCT PREPARATION ISSUE 2 0.0003
603 VENTRICULAR TACHYCARDIA 5 0.0003
604 HAEMATOCRIT DECREASED 6 0.0003
605 HYPOACUSIS 13 0.0003
606 HYPONATRAEMIA 17 0.0003
607 RENAL FAILURE 40 0.0003
608 FLATULENCE 17 0.0003
609 MENINGITIS 2 0.0003
610 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
611 CEREBRAL HAEMATOMA 1 0.0003
612 DRUG LEVEL DECREASED 3 0.0003
613 B-CELL LYMPHOMA 1 0.0003
614 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
615 NEUTROPHIL COUNT INCREASED 3 0.0003
616 EAR DISCOMFORT 3 0.0003
617 HAEMATURIA 10 0.0003
618 APLASIA PURE RED CELL 1 0.0003
619 INTERSTITIAL LUNG DISEASE 14 0.0003
620 ENCEPHALITIS 2 0.0003
621 LARGE INTESTINE POLYP 2 0.0003
622 AUTOIMMUNE HEPATITIS 2 0.0003
623 HYPOMAGNESAEMIA 4 0.0003
624 PNEUMONIA 93 0.0003
625 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
626 PAPULE 2 0.0003
627 SEASONAL ALLERGY 4 0.0003
628 BRONCHOSPASM 4 0.0003
629 PNEUMONIA ASPIRATION 7 0.0003
630 RED BLOOD CELL COUNT DECREASED 8 0.0003
631 HEPATIC ENZYME INCREASED 19 0.0003
632 CONDITION AGGRAVATED 84 0.0003
633 MOUTH HAEMORRHAGE 2 0.0003
634 ASCITES 8 0.0003
635 AMYLASE INCREASED 1 0.0003
636 BLOOD PRESSURE DECREASED 18 0.0003
637 CARDIAC DYSFUNCTION 1 0.0003
638 HAEMORRHAGE INTRACRANIAL 4 0.0003
639 SKIN INFECTION 3 0.0003
640 FISTULA 3 0.0003
641 GASTRITIS 7 0.0003
642 BLOOD SODIUM DECREASED 5 0.0003
643 AUTOIMMUNE THYROIDITIS 1 0.0003
644 HEPATOCELLULAR CARCINOMA 2 0.0003
645 HEART RATE INCREASED 26 0.0003
646 LIPASE INCREASED 2 0.0003
647 GASTRIC HAEMORRHAGE 3 0.0003
648 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
649 DELIRIUM 9 0.0003
650 CARDIOPULMONARY FAILURE 1 0.0003
651 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
652 PRODUCTIVE COUGH 12 0.0003
653 RASH ERYTHEMATOUS 12 0.0003
654 CEREBRAL ATROPHY 1 0.0003
655 DIABETIC KETOACIDOSIS 6 0.0002
656 BLEPHARITIS 1 0.0002
657 CYTOKINE RELEASE SYNDROME 5 0.0002
658 DRUG INTOLERANCE 24 0.0002
659 HICCUPS 2 0.0002
660 HERPES ZOSTER 14 0.0002
661 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
662 SPINAL COMPRESSION FRACTURE 2 0.0002
663 DISEASE PROGRESSION 28 0.0002
664 RENAL DISORDER 11 0.0002
665 HEPATIC CYTOLYSIS 3 0.0002
666 ABSCESS LIMB 1 0.0002
667 FACIAL PARALYSIS 2 0.0002
668 RESPIRATORY DISORDER 7 0.0002
669 BLOOD POTASSIUM DECREASED 7 0.0002
670 DIPLOPIA 6 0.0002
671 OROPHARYNGEAL PAIN 21 0.0002
672 BRAIN NEOPLASM MALIGNANT 1 0.0002
673 PULMONARY OEDEMA 10 0.0002
674 HAEMOLYTIC ANAEMIA 2 0.0002
675 GASTROINTESTINAL INFECTION 2 0.0002
676 JAUNDICE 6 0.0002
677 THERAPY NON-RESPONDER 10 0.0002
678 OEDEMA 12 0.0002
679 INFECTION 32 0.0002
680 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
681 IRON DEFICIENCY ANAEMIA 2 0.0002
682 GRAND MAL CONVULSION 2 0.0002
683 PRODUCT DISTRIBUTION ISSUE 2 0.0002
684 ARTHRITIS INFECTIVE 1 0.0002
685 NEPHROPATHY 2 0.0002
686 BLINDNESS UNILATERAL 3 0.0002
687 PAIN IN JAW 6 0.0002
688 ARRHYTHMIA 10 0.0002
689 HYPERTHYROIDISM 3 0.0002
690 OEDEMA PERIPHERAL 25 0.0002
691 LIGAMENT SPRAIN 2 0.0002
692 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
693 RASH MACULAR 7 0.0002
694 CARDIAC FAILURE 16 0.0002
695 EYELID PTOSIS 2 0.0002
696 DRY THROAT 2 0.0002
697 HYPOPHAGIA 5 0.0002
698 OSTEOPOROSIS 8 0.0002
699 TEMPERATURE INTOLERANCE 2 0.0002
700 POOR VENOUS ACCESS 2 0.0002
701 PETECHIAE 2 0.0002
702 CARDIO-RESPIRATORY ARREST 8 0.0002
703 TRANSFUSION 2 0.0002
704 NEUROPATHY PERIPHERAL 18 0.0002
705 SUDDEN DEATH 2 0.0002
706 ANAL FISTULA 1 0.0002
707 CHEST DISCOMFORT 19 0.0002
708 CHEILITIS 1 0.0002
709 BLOOD POTASSIUM INCREASED 3 0.0002
710 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
711 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
712 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
713 WOUND INFECTION 2 0.0002
714 STEVENS-JOHNSON SYNDROME 4 0.0002
715 PERICARDITIS 3 0.0002
716 ACUTE PULMONARY OEDEMA 1 0.0002
717 OXYGEN SATURATION DECREASED 10 0.0002
718 CHOLECYSTITIS ACUTE 1 0.0002
719 SCAB 2 0.0002
720 PRODUCT USE IN UNAPPROVED INDICATION 43 0.0002
721 CAESAREAN SECTION 2 0.0002
722 OFF LABEL USE 150 0.0002
723 LYMPHADENOPATHY 6 0.0002
724 SOMNOLENCE 34 0.0002
725 RENAL INJURY 5 0.0002
726 PRODUCT PRESCRIBING ERROR 4 0.0002
727 CHOLECYSTITIS 2 0.0002
728 CARDIAC PACEMAKER INSERTION 1 0.0002
729 OSTEOMYELITIS 3 0.0002
730 CEREBRAL INFARCTION 4 0.0002
731 EPILEPSY 5 0.0002
732 ENCEPHALOPATHY 4 0.0002
733 HYPERCALCAEMIA 2 0.0002
734 PHARYNGITIS 2 0.0002
735 SECRETION DISCHARGE 2 0.0002
736 HALLUCINATION 12 0.0002
737 BLEPHAROSPASM 1 0.0002
738 VOMITING 73 0.0002
739 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
740 UNRESPONSIVE TO STIMULI 4 0.0002
741 NODULE 2 0.0002
742 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
743 BLOOD PRESSURE ABNORMAL 3 0.0002
744 FULL BLOOD COUNT DECREASED 3 0.0001
745 DISEASE RECURRENCE 7 0.0001
746 TACHYPNOEA 2 0.0001
747 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
748 BODY TEMPERATURE INCREASED 3 0.0001
749 DRUG TOXICITY 2 0.0001
750 ACUTE HEPATIC FAILURE 2 0.0001
751 TACHYCARDIA 13 0.0001
752 DYSPNOEA 82 0.0001
753 TREATMENT FAILURE 12 0.0001
754 BLISTER 8 0.0001
755 BLOOD TEST ABNORMAL 2 0.0001
756 APPLICATION SITE REACTION 1 0.0001
757 HALLUCINATION, VISUAL 3 0.0001
758 SKIN REACTION 2 0.0001
759 SINUS TACHYCARDIA 2 0.0001
760 INTENTIONAL DOSE OMISSION 4 0.0001
761 LIVER FUNCTION TEST INCREASED 3 0.0001
762 PARALYSIS 2 0.0001
763 CEREBRAL HAEMORRHAGE 5 0.0001
764 LIVER FUNCTION TEST ABNORMAL 4 0.0001
765 FLUID OVERLOAD 2 0.0001
766 VISUAL IMPAIRMENT 17 0.0001
767 DYSPHONIA 8 0.0001
768 MELAENA 3 0.0001
769 URINARY INCONTINENCE 4 0.0001
770 WHEEZING 8 0.0001
771 URINARY TRACT INFECTION 23 0.0001
772 ABDOMINAL DISTENSION 14 0.0001
773 GASTROINTESTINAL DISORDER 12 0.0001
774 DECREASED APPETITE 31 0.0001
775 PANCREATITIS 7 0.0001
776 BRADYCARDIA 7 0.0001
777 BOWEL MOVEMENT IRREGULARITY 1 0.0001
778 SKIN DISCOLOURATION 6 0.0001
779 HYPOTENSION 26 0.0001
780 CHEST PAIN 24 0.0001
781 ATRIOVENTRICULAR BLOCK 1 0.0001
782 ABDOMINAL PAIN 30 0.0001
783 APHTHOUS ULCER 1 0.0001
784 CHILLS 15 0.0001
785 DISORIENTATION 5 0.0001
786 COMA 6 0.0001
787 THERAPY INTERRUPTED 9 0.0001
788 RESPIRATORY TRACT CONGESTION 2 0.0001
789 VISION BLURRED 17 0.0001
790 PRESYNCOPE 3 0.0001
791 NEURALGIA 3 0.0001
792 NAUSEA 97 0.0001
793 RASH 53 0.0001
794 COUGH 34 0.0001
795 DIARRHOEA 78 0.0001
796 RHABDOMYOLYSIS 5 0.0001
797 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
798 HEMIPARESIS 2 0.0001
799 CONFUSIONAL STATE 19 0.0001
800 HEPATITIS 3 0.0001
801 ANAPHYLACTIC SHOCK 3 0.0001
802 SKIN ULCER 3 0.0001
803 NEUROTOXICITY 2 0.0001
804 METASTASES TO LIVER 2 0.0001
805 HYPOXIA 4 0.0001
806 PRODUCT USE ISSUE 21 0.0001
807 DRUG INEFFECTIVE 147 0.0001
808 RASH PRURITIC 6 0.0001
809 PNEUMONITIS 3 0.0001
810 RESTLESSNESS 4 0.0001
811 ASTHENIA 41 0.0001
812 DYSURIA 4 0.0001
813 CONJUNCTIVITIS 2 0.0001
814 ERYTHEMA 22 0.0001
815 EPISTAXIS 8 0.0001
816 HEPATIC CIRRHOSIS 2 0.0001
817 DYSARTHRIA 4 0.0001
818 DYSPNOEA EXERTIONAL 4 0.0001
819 INTESTINAL OBSTRUCTION 4 0.0001
820 GASTRIC ULCER 2 0.0001
821 CONVULSION 6 0.0001
822 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
823 POST PROCEDURAL COMPLICATION 2 0.0001
824 HYPOGLYCAEMIA 5 0.0001
825 SINUS DISORDER 2 0.0001
826 TOXICITY TO VARIOUS AGENTS 17 0.0001
827 IRRITABILITY 6 0.0001
828 ILL-DEFINED DISORDER 6 0.0001
829 NERVOUS SYSTEM DISORDER 3 0.0001
830 SEIZURE 11 0.0001
831 HEAD INJURY 3 0.0001
832 HYPOTHYROIDISM 3 0.0001
833 BREAST PAIN 1 0.0001
834 MOVEMENT DISORDER 3 0.0001
835 PRODUCT DISPENSING ERROR 2 0.0001
836 CHOLELITHIASIS 3 0.0001
837 INFUSION RELATED REACTION 6 0.0001
838 ANAPHYLACTIC REACTION 5 0.0001
839 DEHYDRATION 12 0.0001
840 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
841 HEART RATE DECREASED 3 0.0001
842 BLOOD IRON DECREASED 1 0.0001
843 ATAXIA 1 0.0001
844 SKIN EXFOLIATION 7 0.0001
845 ADRENAL INSUFFICIENCY 1 0.0001
846 ATRIAL FIBRILLATION 8 0.0001
847 VERTIGO 5 0.0001
848 CARDIOMEGALY 1 0.0001
849 BRONCHITIS 6 0.0001
850 DIZZINESS 40 0.0001
851 AGEUSIA 2 0.0001
852 HAEMATEMESIS 2 0.0001
853 INFLAMMATION 4 0.0001
854 RASH GENERALISED 2 0.0001
855 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
856 ECZEMA 4 0.0001
857 BEDRIDDEN 1 0.0001
858 HYPERSENSITIVITY 14 0.0001
859 ADVERSE REACTION 1 0.0001
860 CARDIAC FAILURE CONGESTIVE 6 0.0001
861 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
862 FEAR 2 0.0001
863 DYSPHAGIA 7 0.0001
864 PULMONARY EMBOLISM 7 0.0001
865 LIMB INJURY 2 0.0001
866 BLINDNESS 3 0.0001
867 CONSTIPATION 16 0.0001
868 TREATMENT NONCOMPLIANCE 4 0.0001
869 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
870 RESPIRATORY ARREST 2 0.0001
871 PROCEDURAL PAIN 2 0.0001
872 MEDICATION ERROR 4 0.0001
873 APHONIA 1 0.0001
874 URTICARIA 12 0.0001
875 DYSPEPSIA 7 0.0001
876 MALAISE 31 0.0001
877 PRURITUS 27 0.0001
878 ANGINA PECTORIS 2 0.0001
879 ACCIDENTAL UNDERDOSE 1 0.0001
880 DYSSTASIA 2 0.0001
881 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
882 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
883 WEIGHT DECREASED 19 0.0001
884 DYSGEUSIA 5 0.0001
885 WEIGHT INCREASED 15 0.0001
886 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
887 COVID-19 11 0.0001
888 ABSCESS 1 0.0001
889 NIGHT SWEATS 2 0.0001
890 LACTIC ACIDOSIS 2 0.0001
891 HYPERTENSION 13 0.0001
892 SKIN DISORDER 2 0.0001
893 CELLULITIS 3 0.0001
894 MYALGIA 10 0.0001
895 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
896 NEOPLASM PROGRESSION 2 0.0001
897 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
898 DISTURBANCE IN ATTENTION 3 0.0001
899 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
900 HYPOAESTHESIA 8 0.0001
901 ASTHMA 6 0.0001
902 MUSCULAR WEAKNESS 6 0.0001
903 COLITIS 2 0.0001
904 BLOOD URINE PRESENT 1 0.0001
905 BONE PAIN 3 0.0001
906 NASAL CONGESTION 3 0.0001
907 ABNORMAL BEHAVIOUR 2 0.0001
908 DYSKINESIA 2 0.0000
909 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
910 NASOPHARYNGITIS 9 0.0000
911 TREMOR 8 0.0000
912 POLLAKIURIA 2 0.0000
913 HAEMORRHAGE 5 0.0000
914 LOSS OF CONSCIOUSNESS 6 0.0000
915 DEATH 40 0.0000
916 RHINORRHOEA 3 0.0000
917 OVERDOSE 10 0.0000
918 MENTAL DISORDER 2 0.0000
919 INTENTIONAL PRODUCT MISUSE 4 0.0000
920 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
921 MUSCULOSKELETAL STIFFNESS 4 0.0000
922 HOSPITALISATION 7 0.0000
923 INFLUENZA 5 0.0000
924 INJECTION SITE PRURITUS 3 0.0000
925 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
926 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
927 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
928 NEPHROLITHIASIS 2 0.0000
929 BACK PAIN 10 0.0000
930 BURNING SENSATION 3 0.0000
931 SWELLING 4 0.0000
932 PALPITATIONS 5 0.0000
933 INSOMNIA 11 0.0000
934 AGITATION 3 0.0000
935 SYNCOPE 4 0.0000
936 SINUSITIS 4 0.0000
937 ILLNESS 4 0.0000
938 MUSCULOSKELETAL PAIN 2 0.0000
939 HAEMATOCHEZIA 2 0.0000
940 ARTHRALGIA 15 0.0000
941 DRUG ABUSE 3 0.0000
942 HEADACHE 22 0.0000
943 BALANCE DISORDER 3 0.0000
944 ABDOMINAL PAIN UPPER 7 0.0000
945 ACUTE MYOCARDIAL INFARCTION 1 0.0000
946 DEVICE ISSUE 3 0.0000
947 DISCOMFORT 2 0.0000
948 BLOOD PRESSURE INCREASED 5 0.0000
949 MUSCLE SPASMS 6 0.0000
950 EXPOSURE DURING PREGNANCY 2 0.0000
951 CARDIAC DISORDER 3 0.0000
952 PARAESTHESIA 5 0.0000
953 CONTUSION 3 0.0000
954 HYPERHIDROSIS 4 0.0000
955 DEPRESSION 7 0.0000
956 SWELLING FACE 2 0.0000
957 PRODUCT DOSE OMISSION ISSUE 9 0.0000
958 FALL 10 0.0000
959 ANGER 1 0.0000
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
961 MOBILITY DECREASED 2 0.0000
962 ACCIDENTAL OVERDOSE 1 0.0000
963 PAIN IN EXTREMITY 8 0.0000
964 BLOOD GLUCOSE INCREASED 5 0.0000
965 UNEVALUABLE EVENT 2 0.0000
966 FATIGUE 20 0.0000
967 DRUG DOSE OMISSION BY DEVICE 2 0.0000
968 ARTHRITIS 2 0.0000
969 JOINT SWELLING 3 0.0000
970 ABDOMINAL DISCOMFORT 4 0.0000
971 ANGIOEDEMA 1 0.0000
972 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
973 ADVERSE DRUG REACTION 2 0.0000
974 SUICIDAL IDEATION 2 0.0000
975 ADVERSE EVENT 2 0.0000
976 BLOOD CHOLESTEROL INCREASED 1 0.0000
977 GAIT DISTURBANCE 4 0.0000
978 PERIPHERAL SWELLING 3 0.0000
979 PAIN 11 0.0000
980 ANXIETY 5 0.0000
981 INCORRECT DOSE ADMINISTERED 4 0.0000
982 CATARACT 1 0.0000
983 AMNESIA 1 0.0000
984 DRY SKIN 2 0.0000
985 MEMORY IMPAIRMENT 2 0.0000
986 DRUG DEPENDENCE 2 0.0000
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
988 NO ADVERSE EVENT 2 0.0000
989 BREAST CANCER 1 0.0000
990 ALOPECIA 2 0.0000
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
992 INJECTION SITE PAIN 3 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000